EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral Cannabis sativa Oil Extract, Standardized Based on CBD-A, CBD and THC-A, THC in Canines with Chronic Osteoarthritis

Escobar Torres Benjamin, Silva Elgueta Maria Teresa iD, Navarro Soto Alexander, Suárez Araya Stephanie, Sandoval Contreras Martín, Arrau Barra Sylvia iD

Animals · 13.03.2026 · 16 (6) · 900

DOI: 10.3390/ani16060900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animals, online erschienen am 13.03.2026. Verfasst von Escobar Torres Benjamin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Medicina Veterinaria, Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, La Pirámide 5750, Huechuraba 8580745, Chile. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic osteoarthritis (COA) is a progressive and degenerative condition that causes joint inflammation and pain, often requiring long-term pharmacological management. Conventional treatments may lead to adverse effects, tolerance, and limited analgesic efficacy. This randomized, double-blind clinical trial evaluated the analgesic potential of a full-spectrum Cannabis sativa oil extract administered orally twice daily over six weeks in dogs with COA. Subjects were assigned to three groups: Cannabis, Placebo, and Control. Pain was assessed using the Canine Brief Pain Inventory (CBPI) and the Canine Osteoarthritis Staging Tool (COAST), which ranges from 0 to 4. The Cannabis extract (46.4 mg/mL) total cannabinoids: Cannabidiol (CBD), Cannabidiolic acid (CBDA), Delta-9-Tetrahydrocannabinol (Δ9-THC), and Tetrahydrocannabinolic acid (THCA), were administered using a cautious dose escalation protocol. Treatment began at ~0.1 mg/kg every 12 h, increasing by one drop (1.16 mg) every 72 h. This gradual titration continued until reaching the maximum tolerated dose (2 mg/kg every 12 h), which was maintained for the final two weeks. The protocol was designed to minimize adverse effects and allow close monitoring, especially in geriatric or clinically fragile dogs. By day 28, when the DMT was reached, the Cannabis group showed a 39.6% reduction in CBPI scores, compared to 24.7% in the Placebo group and a 1.6% increase in the Control group. COAST scores improved from level 4 to level 3 in 55.5% of dogs in the Cannabis group, with no changes observed in the other groups. We hypothesize that the co-administration of carprofen, meloxicam, or pregabalin with a full-spectrum Cannabis sativa extract—rich in acidic cannabinoids and terpenes—enhances pain relief and mobility in dogs with COA more effectively than conventional therapies alone. This study aimed to assess the efficacy of an oily full-spectrum Cannabis sativa extract as an adjunctive treatment to NSAIDs in twenty-seven dogs diagnosed with COA, and to compare pain intensity across three treatments groups.

Schlagwörter

Stichwörter der Autor:innen

Cannabidiolanalgesiacannabidiolic acidchronic painfull spectrum extractosteoarthritistetrahydronannabinolic acid

Autor:innen und Institutionen

  • Escuela de Medicina Veterinaria, Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, La Pirámide 5750, Huechuraba 8580745, Chile.
  • Facultad de Medicina, Universidad San Sebastián, Lago Panguipulli 1390, Puerto Montt 5480000, Chile.
  • Clínica Veterinaria Los Pinos, Calle Heraldo Orrego 3011, Local 2, Sector Los Pinos, Quilpué 2340000, Chile.
  • Centro Veterinario Pablo de Rokha, Pedro Prado 12697, La Pintana 8820000, Chile.

ORCID-Profile: Silva Elgueta Maria Teresa, Arrau Barra Sylvia

Zitieren

APA

Benjamin, E. T., Maria Teresa, S. E., Alexander, N. S., Stephanie, S. A., Martín, S. C., & Sylvia, A. B. (2026). Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral Cannabis sativa Oil Extract, Standardized Based on CBD-A, CBD and THC-A, THC in Canines with Chronic Osteoarthritis. Animals, 16(6), 900. https://doi.org/10.3390/ani16060900

Vancouver

Benjamin ET, Maria Teresa SE, Alexander NS, Stephanie SA, Martín SC, Sylvia AB. Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral Cannabis sativa Oil Extract, Standardized Based on CBD-A, CBD and THC-A, THC in Canines with Chronic Osteoarthritis. Animals. 2026;16(6):900. doi:10.3390/ani16060900

BibTeX
@article{Benjamin2026,
  author = {Benjamin, Escobar Torres and Maria Teresa, Silva Elgueta and Alexander, Navarro Soto and Stephanie, Suárez Araya and Martín, Sandoval Contreras and Sylvia, Arrau Barra},
  title = {Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral Cannabis sativa Oil Extract, Standardized Based on CBD-A, CBD and THC-A, THC in Canines with Chronic Osteoarthritis},
  journal = {Animals},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {900},
  doi = {10.3390/ani16060900}
}
Kostenlos starten →